Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 300 entries
Sorted by: Best Match Show Resources per page
Extreme Neuroplasticity of Hippocampal CA1 Pyramidal Neurons in Hibernating Mammalian Species.

Frontiers in neuroanatomy

Horowitz JM, Horwitz BA.
PMID: 30814935
Front Neuroanat. 2019 Feb 13;13:9. doi: 10.3389/fnana.2019.00009. eCollection 2019.

In awake and behaving mammals (with core and brain temperatures at ~37°C), hippocampal neurons have anatomical and physiological properties that support formation of memories. However, studies of hibernating mammalian species suggest that as hippocampal temperature falls to values below...

Cite
Horowitz JM, Horwitz BA. Extreme Neuroplasticity of Hippocampal CA1 Pyramidal Neurons in Hibernating Mammalian Species. Front Neuroanat. 2019;13:9doi: 10.3389/fnana.2019.00009.
Horowitz, J. M., & Horwitz, B. A. (2019). Extreme Neuroplasticity of Hippocampal CA1 Pyramidal Neurons in Hibernating Mammalian Species. Frontiers in neuroanatomy, 139. https://doi.org/10.3389/fnana.2019.00009
Horowitz, John M, and Horwitz, Barbara A. "Extreme Neuroplasticity of Hippocampal CA1 Pyramidal Neurons in Hibernating Mammalian Species." Frontiers in neuroanatomy vol. 13 (2019): 9. doi: https://doi.org/10.3389/fnana.2019.00009
Horowitz JM, Horwitz BA. Extreme Neuroplasticity of Hippocampal CA1 Pyramidal Neurons in Hibernating Mammalian Species. Front Neuroanat. 2019 Feb 13;13:9. doi: 10.3389/fnana.2019.00009. eCollection 2019. PMID: 30814935; PMCID: PMC6381046.
Copy Download .nbib Format: NLM
Strain-Controlled Superconductivity in Few-Layer NbSe.

ACS applied materials & interfaces

Chen C, Das P, Aytan E, Zhou W, Horowitz J, Satpati B, Balandin AA, Lake RK, Wei P.
PMID: 32805977
ACS Appl Mater Interfaces. 2020 Aug 26;12(34):38744-38750. doi: 10.1021/acsami.0c08804. Epub 2020 Aug 18.

The controlled tunability of superconductivity in low-dimensional materials may enable new quantum devices. Particularly in triplet or topological superconductors, tunneling devices such as Josephson junctions, etc., can demonstrate exotic functionalities. The tunnel barrier, an insulating or normal material layer...

Cite
Chen C, Das P, Aytan E, et al. Strain-Controlled Superconductivity in Few-Layer NbSe. ACS Appl Mater Interfaces. 2020;12(34):38744-38750doi: 10.1021/acsami.0c08804.
Chen, C., Das, P., Aytan, E., Zhou, W., Horowitz, J., Satpati, B., Balandin, A. A., Lake, R. K., & Wei, P. (2020). Strain-Controlled Superconductivity in Few-Layer NbSe. ACS applied materials & interfaces, 12(34), 38744-38750. https://doi.org/10.1021/acsami.0c08804
Chen, Cliff, et al. "Strain-Controlled Superconductivity in Few-Layer NbSe." ACS applied materials & interfaces vol. 12,34 (2020): 38744-38750. doi: https://doi.org/10.1021/acsami.0c08804
Chen C, Das P, Aytan E, Zhou W, Horowitz J, Satpati B, Balandin AA, Lake RK, Wei P. Strain-Controlled Superconductivity in Few-Layer NbSe. ACS Appl Mater Interfaces. 2020 Aug 26;12(34):38744-38750. doi: 10.1021/acsami.0c08804. Epub 2020 Aug 18. PMID: 32805977.
Copy Download .nbib Format: NLM
CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION.

Retinal cases & brief reports

Fan J, Gong D, Truong C, Miko B, Horowitz J, Chen RWS.
PMID: 31568220
Retin Cases Brief Rep. 2019 Sep 23; doi: 10.1097/ICB.0000000000000928. Epub 2019 Sep 23.

PURPOSE: To report two cases of cytomegalovirus (CMV) retinitis in renal transplant patients after conversion to belatacept immunosuppression.METHODS: Case report.RESULTS: Case A was a 41-year-old African American man with no ocular history, chronic hepatitis B infection on entecavir, status-post...

Cite
Fan J, Gong D, Truong C, et al. CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION. Retin Cases Brief Rep. 2019;doi: 10.1097/ICB.0000000000000928.
Fan, J., Gong, D., Truong, C., Miko, B., Horowitz, J., & Chen, R. W. S. (2019). CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION. Retinal cases & brief reports, . https://doi.org/10.1097/ICB.0000000000000928
Fan, Jason, et al. "CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION." Retinal cases & brief reports vol. (2019). doi: https://doi.org/10.1097/ICB.0000000000000928
Fan J, Gong D, Truong C, Miko B, Horowitz J, Chen RWS. CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION. Retin Cases Brief Rep. 2019 Sep 23; doi: 10.1097/ICB.0000000000000928. Epub 2019 Sep 23. PMID: 31568220.
Copy Download .nbib Format: NLM
Role of Complement Activation in Allograft Inflammation.

Current transplantation reports

Chun N, Horwitz J, Heeger PS.
PMID: 31673484
Curr Transplant Rep. 2019 Mar;6(1):52-59. doi: 10.1007/s40472-019-0224-2. Epub 2019 Jan 15.

PURPOSE: Novel paradigms have broadened our understanding of mechanisms through which complement mediates allograft inflammation/injury. Herein we review advances in the field and highlight therapeutic implications.RECENT FINDINGS: Pre-clinical and translational human trials have elucidated complement-dependent mechanisms of post-transplant ischemia-reperfusion...

Cite
Chun N, Horwitz J, Heeger PS. Role of Complement Activation in Allograft Inflammation. Curr Transplant Rep. 2019;6(1):52-59doi: 10.1007/s40472-019-0224-2.
Chun, N., Horwitz, J., & Heeger, P. S. (2019). Role of Complement Activation in Allograft Inflammation. Current transplantation reports, 6(1), 52-59. https://doi.org/10.1007/s40472-019-0224-2
Chun, Nicholas, et al. "Role of Complement Activation in Allograft Inflammation." Current transplantation reports vol. 6,1 (2019): 52-59. doi: https://doi.org/10.1007/s40472-019-0224-2
Chun N, Horwitz J, Heeger PS. Role of Complement Activation in Allograft Inflammation. Curr Transplant Rep. 2019 Mar;6(1):52-59. doi: 10.1007/s40472-019-0224-2. Epub 2019 Jan 15. PMID: 31673484; PMCID: PMC6822566.
Copy Download .nbib Format: NLM
Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy.

JAMA oncology

Perni S, Rooney MK, Horowitz DP, Golden DW, McCall AR, Einstein AJ, Jagsi R.
PMID: 31046122
JAMA Oncol. 2019 Aug 01;5(8):e190260. doi: 10.1001/jamaoncol.2019.0260. Epub 2019 Aug 08.

IMPORTANCE: Appropriate informed consent processes are crucial to preservation of patient autonomy and shared decision making. Although half of patients with cancer receive radiotherapy, it is unknown whether current consent practices are comprehensible for patients.OBJECTIVE: To characterize use, specificity,...

Cite
Perni S, Rooney MK, Horowitz DP, et al. Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy. JAMA Oncol. 2019;5(8):e190260doi: 10.1001/jamaoncol.2019.0260.
Perni, S., Rooney, M. K., Horowitz, D. P., Golden, D. W., McCall, A. R., Einstein, A. J., & Jagsi, R. (2019). Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy. JAMA oncology, 5(8), e190260. https://doi.org/10.1001/jamaoncol.2019.0260
Perni, Subha, et al. "Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy." JAMA oncology vol. 5,8 (2019): e190260. doi: https://doi.org/10.1001/jamaoncol.2019.0260
Perni S, Rooney MK, Horowitz DP, Golden DW, McCall AR, Einstein AJ, Jagsi R. Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy. JAMA Oncol. 2019 Aug 01;5(8):e190260. doi: 10.1001/jamaoncol.2019.0260. Epub 2019 Aug 08. PMID: 31046122; PMCID: PMC6499131.
Copy Download .nbib Format: NLM
Acute pulmonary embolism: endovascular therapy.

Cardiovascular diagnosis and therapy

Reis SP, Zhao K, Ahmad N, Widemon RS, Root CW, Toomay SM, Horowitz JM, Sista AK.
PMID: 30057873
Cardiovasc Diagn Ther. 2018 Jun;8(3):244-252. doi: 10.21037/cdt.2017.12.05.

Pulmonary embolism (PE) is a leading cause of morbidity and mortality worldwide. PE is a complex disease with a highly variable presentation and the available treatment options for PE are expanding rapidly. Anticoagulation (AC), systemic lysis, surgery, and catheter-directed...

Cite
Reis SP, Zhao K, Ahmad N, et al. Acute pulmonary embolism: endovascular therapy. Cardiovasc Diagn Ther. 2018;8(3):244-252doi: 10.21037/cdt.2017.12.05.
Reis, S. P., Zhao, K., Ahmad, N., Widemon, R. S., Root, C. W., Toomay, S. M., Horowitz, J. M., & Sista, A. K. (2018). Acute pulmonary embolism: endovascular therapy. Cardiovascular diagnosis and therapy, 8(3), 244-252. https://doi.org/10.21037/cdt.2017.12.05
Reis, Stephen P, et al. "Acute pulmonary embolism: endovascular therapy." Cardiovascular diagnosis and therapy vol. 8,3 (2018): 244-252. doi: https://doi.org/10.21037/cdt.2017.12.05
Reis SP, Zhao K, Ahmad N, Widemon RS, Root CW, Toomay SM, Horowitz JM, Sista AK. Acute pulmonary embolism: endovascular therapy. Cardiovasc Diagn Ther. 2018 Jun;8(3):244-252. doi: 10.21037/cdt.2017.12.05. PMID: 30057873; PMCID: PMC6039803.
Copy Download .nbib Format: NLM
A case of emphysematous cystitis and bladder rupture.

Urology case reports

Hudnall MT, Jordan BJ, Horowitz J, Kielb S.
PMID: 31211071
Urol Case Rep. 2019 Mar 06;24:100860. doi: 10.1016/j.eucr.2019.100860. eCollection 2019 May.

This is a case of emphysematous cystitis with a rare complication of bladder rupture requiring surgical intervention in a diabetic man who presented with urinary retention and abdominal pain, with a large amount of intraperitoneal free air on computed...

Cite
Hudnall MT, Jordan BJ, Horowitz J, et al. A case of emphysematous cystitis and bladder rupture. Urol Case Rep. 2019;24:100860doi: 10.1016/j.eucr.2019.100860.
Hudnall, M. T., Jordan, B. J., Horowitz, J., & Kielb, S. (2019). A case of emphysematous cystitis and bladder rupture. Urology case reports, 24100860. https://doi.org/10.1016/j.eucr.2019.100860
Hudnall, Matthew T, et al. "A case of emphysematous cystitis and bladder rupture." Urology case reports vol. 24 (2019): 100860. doi: https://doi.org/10.1016/j.eucr.2019.100860
Hudnall MT, Jordan BJ, Horowitz J, Kielb S. A case of emphysematous cystitis and bladder rupture. Urol Case Rep. 2019 Mar 06;24:100860. doi: 10.1016/j.eucr.2019.100860. eCollection 2019 May. PMID: 31211071; PMCID: PMC6562318.
Copy Download .nbib Format: NLM
Self-force of a classical charged particle.

Physical review. A, Atomic, molecular, and optical physics

Horwitz LP, Ianconescu R.
PMID: 9907509
Phys Rev A. 1992 Apr 01;45(7):4346-4354. doi: 10.1103/physreva.45.4346.

No abstract available.

Cite
Horwitz LP, Ianconescu R. Self-force of a classical charged particle. Phys Rev A. 1992;45(7):4346-4354doi: 10.1103/physreva.45.4346.
Horwitz, L. P., & Ianconescu, R. (1992). Self-force of a classical charged particle. Physical review. A, Atomic, molecular, and optical physics, 45(7), 4346-4354. https://doi.org/10.1103/physreva.45.4346
Horwitz, and Ianconescu. "Self-force of a classical charged particle." Physical review. A, Atomic, molecular, and optical physics vol. 45,7 (1992): 4346-4354. doi: https://doi.org/10.1103/physreva.45.4346
Horwitz LP, Ianconescu R. Self-force of a classical charged particle. Phys Rev A. 1992 Apr 01;45(7):4346-4354. doi: 10.1103/physreva.45.4346. PMID: 9907509.
Copy Download .nbib Format: NLM
A Statewide Collaborative Quality Initiative To Improve Antibiotic Duration And Outcomes Of Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Vaughn VM, Gandhi TN, Hofer TP, Petty LA, Malani AN, Osterholzer D, Dumkow LE, Ratz D, Horowitz JK, McLaughlin ES, Czilok T, Flanders SA.
PMID: 34791085
Clin Infect Dis. 2021 Nov 13; doi: 10.1093/cid/ciab950. Epub 2021 Nov 13.

BACKGROUND: Community-acquired pneumonia (CAP) is a common cause for hospitalization and antibiotic overuse. We aimed to improve antibiotic duration for CAP across 41 hospitals participating in the Michigan Hospital Medicine Safety Consortium (HMS).METHODS: Prospective collaborative quality initiative including patients...

Cite
Vaughn VM, Gandhi TN, Hofer TP, et al. A Statewide Collaborative Quality Initiative To Improve Antibiotic Duration And Outcomes Of Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab950.
Vaughn, V. M., Gandhi, T. N., Hofer, T. P., Petty, L. A., Malani, A. N., Osterholzer, D., Dumkow, L. E., Ratz, D., Horowitz, J. K., McLaughlin, E. S., Czilok, T., & Flanders, S. A. (2021). A Statewide Collaborative Quality Initiative To Improve Antibiotic Duration And Outcomes Of Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab950
Vaughn, Valerie M, et al. "A Statewide Collaborative Quality Initiative To Improve Antibiotic Duration And Outcomes Of Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab950
Vaughn VM, Gandhi TN, Hofer TP, Petty LA, Malani AN, Osterholzer D, Dumkow LE, Ratz D, Horowitz JK, McLaughlin ES, Czilok T, Flanders SA. A Statewide Collaborative Quality Initiative To Improve Antibiotic Duration And Outcomes Of Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia. Clin Infect Dis. 2021 Nov 13; doi: 10.1093/cid/ciab950. Epub 2021 Nov 13. PMID: 34791085.
Copy Download .nbib Format: NLM
A catalog of associations between rare coding variants and COVID-19 outcomes.

medRxiv : the preprint server for health sciences

Kosmicki JA, Horowitz JE, Banerjee N, Lanche R, Marcketta A, Maxwell E, Bai X, Sun D, Backman JD, Sharma D, Kang HM, O'Dushlaine C, Yadav A, Mansfield AJ, Li AH, Watanabe K, Gurski L, McCarthy SE, Locke AE, Khalid S, O'Keeffe S, Mbatchou J, Chazara O, Huang Y, Kvikstad E, O'Neill A, Nioi P, Parker MM, Petrovski S, Runz H, Szustakowski JD, Wang Q, Wong E, Cordova-Palomera A, Smith EN, Szalma S, Zheng X, Esmaeeli S, Davis JW, Lai YP, Chen X, Justice AE, Leader JB, Mirshahi T, Carey DJ, Verma A, Sirugo G, Ritchie MD, Rader DJ, Povysil G, Goldstein DB, Kiryluk K, Pairo-Castineira E, Rawlik K, Pasko D, Walker S, Meynert A, Kousathanas A, Moutsianas L, Tenesa A, Caulfield M, Scott R, Wilson JF, Baillie JK, Butler-Laporte G, Nakanishi T, Lathrop M, Richards JB, Jones M, Balasubramanian S, Salerno W, Shuldiner AR, Marchini J, Overton JD, Habegger L, Cantor MN, Reid JG, Baras A, Abecasis GR, Ferreira MA.
PMID: 33655273
medRxiv. 2021 Feb 27; doi: 10.1101/2020.10.28.20221804.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19), a respiratory illness that can result in hospitalization or death. We investigated associations between rare genetic variants and seven COVID-19 outcomes in 543,213 individuals, including 8,248 with COVID-19. After...

Cite
Kosmicki JA, Horowitz JE, Banerjee N, et al. A catalog of associations between rare coding variants and COVID-19 outcomes. medRxiv. 2021;doi: 10.1101/2020.10.28.20221804.
Kosmicki, J. A., Horowitz, J. E., Banerjee, N., Lanche, R., Marcketta, A., Maxwell, E., Bai, X., Sun, D., Backman, J. D., Sharma, D., Kang, H. M., O'Dushlaine, C., Yadav, A., Mansfield, A. J., Li, A. H., Watanabe, K., Gurski, L., McCarthy, S. E., Locke, A. E., Khalid, S., O'Keeffe, S., Mbatchou, J., Chazara, O., Huang, Y., Kvikstad, E., O'Neill, A., Nioi, P., Parker, M. M., Petrovski, S., Runz, H., Szustakowski, J. D., Wang, Q., Wong, E., Cordova-Palomera, A., Smith, E. N., Szalma, S., Zheng, X., Esmaeeli, S., Davis, J. W., Lai, Y. P., Chen, X., Justice, A. E., Leader, J. B., Mirshahi, T., Carey, D. J., Verma, A., Sirugo, G., Ritchie, M. D., Rader, D. J., Povysil, G., Goldstein, D. B., Kiryluk, K., Pairo-Castineira, E., Rawlik, K., Pasko, D., Walker, S., Meynert, A., Kousathanas, A., Moutsianas, L., Tenesa, A., Caulfield, M., Scott, R., Wilson, J. F., Baillie, J. K., Butler-Laporte, G., Nakanishi, T., Lathrop, M., Richards, J. B., Jones, M., Balasubramanian, S., Salerno, W., Shuldiner, A. R., Marchini, J., Overton, J. D., Habegger, L., Cantor, M. N., Reid, J. G., Baras, A., Abecasis, G. R., & Ferreira, M. A. (2021). A catalog of associations between rare coding variants and COVID-19 outcomes. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.10.28.20221804
Kosmicki, J A, et al. "A catalog of associations between rare coding variants and COVID-19 outcomes." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2020.10.28.20221804
Kosmicki JA, Horowitz JE, Banerjee N, Lanche R, Marcketta A, Maxwell E, Bai X, Sun D, Backman JD, Sharma D, Kang HM, O'Dushlaine C, Yadav A, Mansfield AJ, Li AH, Watanabe K, Gurski L, McCarthy SE, Locke AE, Khalid S, O'Keeffe S, Mbatchou J, Chazara O, Huang Y, Kvikstad E, O'Neill A, Nioi P, Parker MM, Petrovski S, Runz H, Szustakowski JD, Wang Q, Wong E, Cordova-Palomera A, Smith EN, Szalma S, Zheng X, Esmaeeli S, Davis JW, Lai YP, Chen X, Justice AE, Leader JB, Mirshahi T, Carey DJ, Verma A, Sirugo G, Ritchie MD, Rader DJ, Povysil G, Goldstein DB, Kiryluk K, Pairo-Castineira E, Rawlik K, Pasko D, Walker S, Meynert A, Kousathanas A, Moutsianas L, Tenesa A, Caulfield M, Scott R, Wilson JF, Baillie JK, Butler-Laporte G, Nakanishi T, Lathrop M, Richards JB, Jones M, Balasubramanian S, Salerno W, Shuldiner AR, Marchini J, Overton JD, Habegger L, Cantor MN, Reid JG, Baras A, Abecasis GR, Ferreira MA. A catalog of associations between rare coding variants and COVID-19 outcomes. medRxiv. 2021 Feb 27; doi: 10.1101/2020.10.28.20221804. PMID: 33655273; PMCID: PMC7924298.
Copy Download .nbib Format: NLM
Mental health outcomes after hospitalization with or without COVID-19.

General hospital psychiatry

Spencer-Segal JL, Smith CA, Slavin A, Sampang L, DiGiovine D, Spencer AE, Zhang Q, Horowitz J, Vaughn VM.
PMID: 34301426
Gen Hosp Psychiatry. 2021 Sep-Oct;72:152-153. doi: 10.1016/j.genhosppsych.2021.07.004. Epub 2021 Jul 17.

No abstract available.

Cite
Spencer-Segal JL, Smith CA, Slavin A, et al. Mental health outcomes after hospitalization with or without COVID-19. Gen Hosp Psychiatry. 2021;72:152-153doi: 10.1016/j.genhosppsych.2021.07.004.
Spencer-Segal, J. L., Smith, C. A., Slavin, A., Sampang, L., DiGiovine, D., Spencer, A. E., Zhang, Q., Horowitz, J., & Vaughn, V. M. (2021). Mental health outcomes after hospitalization with or without COVID-19. General hospital psychiatry, 72152-153. https://doi.org/10.1016/j.genhosppsych.2021.07.004
Spencer-Segal, Joanna L, et al. "Mental health outcomes after hospitalization with or without COVID-19." General hospital psychiatry vol. 72 (2021): 152-153. doi: https://doi.org/10.1016/j.genhosppsych.2021.07.004
Spencer-Segal JL, Smith CA, Slavin A, Sampang L, DiGiovine D, Spencer AE, Zhang Q, Horowitz J, Vaughn VM. Mental health outcomes after hospitalization with or without COVID-19. Gen Hosp Psychiatry. 2021 Sep-Oct;72:152-153. doi: 10.1016/j.genhosppsych.2021.07.004. Epub 2021 Jul 17. PMID: 34301426; PMCID: PMC8285222.
Copy Download .nbib Format: NLM
Manhattan Vision Screening and Follow-Up Study in Vulnerable Populations: 1-Month Feasibility Results.

Current eye research

Hark LA, Tan CS, Kresch YS, De Moraes CG, Horowitz JD, Park L, Auran JD, Gorroochurn P, Stempel S, Maruri SC, Besagar S, Saaddine JB, Lambert BC, Pizzi LT, Sapru S, Price S, Williams OA, Cioffi GA, Liebmann JM.
PMID: 33726583
Curr Eye Res. 2021 Oct;46(10):1597-1604. doi: 10.1080/02713683.2021.1905000. Epub 2021 Apr 19.

No abstract available.

Cite
Hark LA, Tan CS, Kresch YS, et al. Manhattan Vision Screening and Follow-Up Study in Vulnerable Populations: 1-Month Feasibility Results. Curr Eye Res. 2021;46(10):1597-1604doi: 10.1080/02713683.2021.1905000.
Hark, L. A., Tan, C. S., Kresch, Y. S., De Moraes, C. G., Horowitz, J. D., Park, L., Auran, J. D., Gorroochurn, P., Stempel, S., Maruri, S. C., Besagar, S., Saaddine, J. B., Lambert, B. C., Pizzi, L. T., Sapru, S., Price, S., Williams, O. A., Cioffi, G. A., & Liebmann, J. M. (2021). Manhattan Vision Screening and Follow-Up Study in Vulnerable Populations: 1-Month Feasibility Results. Current eye research, 46(10), 1597-1604. https://doi.org/10.1080/02713683.2021.1905000
Hark, Lisa A, et al. "Manhattan Vision Screening and Follow-Up Study in Vulnerable Populations: 1-Month Feasibility Results." Current eye research vol. 46,10 (2021): 1597-1604. doi: https://doi.org/10.1080/02713683.2021.1905000
Hark LA, Tan CS, Kresch YS, De Moraes CG, Horowitz JD, Park L, Auran JD, Gorroochurn P, Stempel S, Maruri SC, Besagar S, Saaddine JB, Lambert BC, Pizzi LT, Sapru S, Price S, Williams OA, Cioffi GA, Liebmann JM. Manhattan Vision Screening and Follow-Up Study in Vulnerable Populations: 1-Month Feasibility Results. Curr Eye Res. 2021 Oct;46(10):1597-1604. doi: 10.1080/02713683.2021.1905000. Epub 2021 Apr 19. PMID: 33726583.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 300 entries